潤都股份(002923.SZ):在研1類創新藥爲鹽酸去甲烏藥鹼注射液及其原料藥
格隆匯6月11日丨潤都股份(002923.SZ)於投資者互動平臺表示,公司在研1類創新藥爲鹽酸去甲烏藥鹼注射液(規格:2ml:2.5mg)及其原料藥。鹽酸去甲烏藥鹼是在發現中藥附子有效成分的基礎上,化學方法合成(相比植物提取,也更容易獲得穩定的質量和收率)的一種腎上腺β受體部分激動劑,可以使心肌收縮力增強。鹽酸去甲烏藥鹼注射液可作爲心臟負荷試驗藥物用於核素心肌灌注顯像,以輔助診斷和評估心肌缺血。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.